Western biotechs are getting a new playbook with tighter controls to stay ahead of an ultraefficient pharmaceutical pipeline overseas.
Western biotechs are getting a new playbook with tighter controls to stay ahead of an ultraefficient pharmaceutical pipeline overseas.